Key statistics
As of last trade, DEXCOM INC DRN (D1EX34:SAO) traded at 8.65, 23.04% above the 52 week low of 7.03 set on Oct 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.81 |
---|---|
High | 8.81 |
Low | 8.65 |
Bid | 8.47 |
Offer | 8.51 |
Previous close | 8.76 |
Average volume | 517.67 |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 22 2024 17:59 GMT.
More ▼
Press releases
- Dexcom and ŌURA Announce Strategic Partnership
- Dexcom Helps People With Diabetes Take the First Step to Discover What They’re Made Of on World Diabetes Day
- Dexcom Reports Third Quarter 2024 Financial Results
- Dexcom Schedules Third Quarter 2024 Earnings Release and Conference Call for October 24, 2024 at 4:30 p.m. Eastern Time.
- Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
- Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
- Dexcom CGM Worn in Outer Space as Part of First-of-its-Kind Polaris Dawn Mission
- Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
- Dexcom Announces Upcoming Conference Presentation
- Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
More ▼